Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Repeated dose toxicity: oral

Currently viewing:

Administrative data

sub-chronic toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: Guideline study.

Data source

Reference Type:
study report

Materials and methods

Test guideline
according to guideline
OECD Guideline 408 (Repeated Dose 90-Day Oral Toxicity Study in Rodents)
Principles of method if other than guideline:
Method: other: 10 rats/group and sex
GLP compliance:
Limit test:

Test material

Constituent 1
Chemical structure
Reference substance name:
C14-17 alkanes, sec-mono- and disulfonic acids, phenyl esters
EC Number:
C14-17 alkanes, sec-mono- and disulfonic acids, phenyl esters
Test material form:

Test animals

other: Bor: WISW

Administration / exposure

Route of administration:
oral: feed
other: test substance administered with food
Analytical verification of doses or concentrations:
Duration of treatment / exposure:
90 days
Frequency of treatment:
Doses / concentrations
Doses / Concentrations:
750; 3000; 12000 ppm (dosage males:   55.4; 228.0;  985.2 mg/kg b.w./day (calculated)  dosage females: 68.7; 282.6; 1488.5 mg/kg b.w./day (calculated))

No. of animals per sex per dose:
Control animals:
Details on study design:
Post-exposure period: no

Results and discussion

Results of examinations

Clinical signs:
no effects observed
no mortality observed
Body weight and weight changes:
effects observed, treatment-related
Food consumption and compound intake (if feeding study):
effects observed, treatment-related
Water consumption and compound intake (if drinking water study):
effects observed, treatment-related
Ophthalmological findings:
no effects observed
Haematological findings:
effects observed, treatment-related
Clinical biochemistry findings:
no effects observed
Urinalysis findings:
no effects observed
Organ weight findings including organ / body weight ratios:
no effects observed
Gross pathological findings:
no effects observed
Histopathological findings: non-neoplastic:
no effects observed
Histopathological findings: neoplastic:
no effects observed

Effect levels

Dose descriptor:
Effect level:
3 000 ppm
Basis for effect level:
other: In the highest dose group of 12000 ppm the female rats consumed more food and the male rats had an increased water consume and a slightly increased tromboplastin-time was observed in male rats at 12000 ppm.

Target system / organ toxicity

Critical effects observed:
not specified

Any other information on results incl. tables

dosage males:   55.4; 228.0;  985.2 mg/kg b.w./day
dosage females: 68.7; 282.6; 1488.5 mg/kg b.w./day

no death, no effect on behaviour, reduced body weight gain, increased  feed 

(females) and water consumption (males) at the high dose level,  absolute and

relative liver weight is significantly dose-related  increased at all dose 

levels, kidney weight only increased at the high  dose level, no 

substance-related histopathological effects (47 organs and  tissue), 

opthalmological, hematological and clinical- chemical parameters  within the 

normal range, slightly increased tromboplastin/time at the  high dose.

Applicant's summary and conclusion

Executive summary:

In a subchronical 3 month-feeding study male and female rats received the test substance via food in following doses: 0 (control-group); 750; 3000; 12000 ppm.

No mortalities and no effects on behaviour were observed.

Food and water intake were not modified up to 3000 ppm. In the highest dose group of 12000 ppm the female rats consumed more food and the male rats had an increased water consume.

The growth was delayed in male and femal rats in the highest dose group.

The absolute and relative liver weight was significantly dose-related increased at all dose levels, but the kidney weight only increased at the high dose level. No substance related histopatological effects (aorta, eyes with lids, cecum, duodenum, femur, brain, bladder, testicles, skin, heart, pituitary gland, larynx, head, ileum, jejunum, liver, lung, mesenterial lymph node, mandibular lymph node, stomach, lactiferous gland, spleen, femoral musculature, epididymis, nervus ischiadicus, nervus opticus, kidneys, esophagus, ovaries, oviduct, pancreas, prostata, rectum, cervical, thoracal and lumbal spinal cord, seminal vesicle, thyroid gland, salivary gland, sternum, thymus (if present), trachea, extraorbitary lacrimal gland, uterus, vagina, tongue) were observed.

Ophtalmological, hematological and clinical parameters were within the normal range.

Only a slightly increased tromboplastin-time was observed in male rats at 12000 ppm.

The NOAEL for male and female rats therefore is 3000 ppm.